8-K//Current report
Apellis Pharmaceuticals, Inc. 8-K
Accession 0001193125-24-155179
$APLSCIK 0001492422operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:50 PM ET
Size
150.4 KB
Accession
0001193125-24-155179
Documents
- 8-Kd816010d8k.htmPrimary
8-K
- EX-101.SCHapls-20240605.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABapls-20240605_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREapls-20240605_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-24-155179-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd816010d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492422
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:50 PM ET
- Size
- 150.4 KB